A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART

• Jackson AG,
• Kløverpris HN,
• Handley A,
• Hayes P,
• Gilmour J,
• Atkins M,
• Walker B,
• Ackland J,
• Sullivan M,
• Goulder P

Affiliations

Jackson AG

Kløverpris HN

Handley A

Hayes P

Gilmour J

Atkins M

Walker B

Ackland J

Sullivan M

Goulder P